Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Citi
Fish and Richardson
McKinsey
Teva
UBS
Merck
Cipla
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

MIBELAS 24 FE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Mibelas 24 Fe patents expire, and what generic alternatives are available?

Mibelas 24 Fe is a drug marketed by Lupin Atlantis and is included in one NDA.

The generic ingredient in MIBELAS 24 FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for MIBELAS 24 FE
Drug patent expirations by year for MIBELAS 24 FE

US Patents and Regulatory Information for MIBELAS 24 FE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Atlantis MIBELAS 24 FE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE;ORAL 206287-001 May 24, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Cipla
Queensland Health
Federal Trade Commission
Chinese Patent Office
AstraZeneca
Chubb
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.